Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593684 · ClinicalTrials.gov registry record · NA
The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00593684 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 50 participants.
The verdict
NCT00593684, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety of silver alginate (Algidex™) dressing in VLBW infants in preparation for a large efficacy trial.
Interventions
- DEVICE Silver Alginate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593684
The ClinicalTrials.gov registry entry for NCT00593684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Silver Alginate is the first listed.
NCT00593684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00593684 about?
NCT00593684 is a clinical study titled "The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants". The purpose of this study is to test the safety of silver alginate (Algidex™) dressing in VLBW infants in preparation for a large efficacy trial.
What is the current status of trial NCT00593684?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2006-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00593684?
The interventions under investigation include: Silver Alginate (DEVICE).
Who is sponsoring clinical trial NCT00593684?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.